July 17, 2020
UAE begins Phase III trial of Sinopharm COVID-19 vaccine
The world’s first Phase III trial is the result of a cooperation partnership between Abu Dhabi based G42 Healthcare, currently at the forefront of the battle against COVID-19 in the UAE, and Sinopharm CNBG, the world’s sixth largest vaccine manufacturer, ranked 169th on the Fortune Global 500 list of 2018.
June 25, 2020
Mubadala healthcare facilities achieve ‘COVID-FREE’ status
Patient safety is the highest priority across Mubadala Healthcare, with Cleveland Clinic Abu Dhabi, Healthpoint, and Imperial College London Diabetes Centre (ICLDC) resuming their most sought-after medical services while staff and patients stringently follow all precautionary measures including mask wearing, physical distancing, and temperature scans.
May 10, 2020
MBZUAI appoints AI scientist Ling Shao as EVP and Provost
In addition to his new role at MBZUAI, Dr. Shao also serves as CEO and Chief Scientist of the Inception Institute of Artificial Intelligence (IIAI), an Abu Dhabi-based international research organization dedicated to achieving breakthroughs in fundamental and applied AI research.
February 16, 2020
Public Cloud Services in the MENA region to Grow 21% in 2020
Government initiatives such as Smart Dubai, Smart Abu Dhabi, Israel’s Cloud Strategy and Bahrain’s Cloud First Policy of 2019 have bolstered cloud adoption among large organizations in the region,” said Sid Nag, research vice president at Gartner.
